Elevated serum C1q is an independent predictor of high residual platelet reactivity in CAD patients receiving clopidogrel therapy

Elevated serum C1q is an independent predictor of high residual platelet reactivity in CAD patients receiving clopidogrel therapy

BackgroundInflammation increases the risk of thrombosis in coronary artery disease (CAD) patients and affects the antiplatelet efficacy of clopidogrel. C1q interacts with platelets to activate platelets and induce thrombosis by participating in and regulating the inflammatory response. Whether C1q a...

Full description

Bibliographic Details
Main Authors: Zehao Zhao, Meishi Ma, Xin Huang, Tienan Sun, Kangning Han, Shiwei Yang, Yujie Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Immunology
Subjects:
clopidogrel
complement C1q
platelet activity
thromboelastography
percutaneous coronary intervention
coronary artery disease
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.969984/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.969984/full

Similar Items